Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PACS Group between (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued… Continue reading DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PACS Group
Tag: M and A
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing Kyverna common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering… Continue reading DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Israeli Doctors from Save a Child’s Heart Deliver Christmas Miracles to Zambian Children
ROCKVILLE, Md., Dec. 24, 2024 /PRNewswire/ — In the spirit of the Christmas season, a team of Israeli doctors recently completed a humanitarian mission to Zambia, bringing hope and healing to 25 children suffering from critical heart conditions. The medical mission, a testament to the true meaning of Christmas – compassion, generosity, and the gift… Continue reading Israeli Doctors from Save a Child’s Heart Deliver Christmas Miracles to Zambian Children
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DMC
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In DMC To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in DMC between May 3, 2024 and November 4, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi… Continue reading DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DMC
Velo3D Announces Debt for Equity Exchange Transaction Significantly Delevers Balance Sheet Arrayed Notes Acquisition Corp to Become Majority Equity Holder of Velo3D
81.7% of the outstanding senior secured notes to be cancelled Velo3D Board of Directors Unanimously Approved the Transaction Velo3D to remain a public Company and continue to serve its customers FREMONT, Calif., Dec. 24, 2024 /PRNewswire/ — Velo3D, Inc. (OTCQX: VLDX) (“Velo3D” or the “Company”), the leader in scalable metal 3D printing technology for production… Continue reading Velo3D Announces Debt for Equity Exchange Transaction Significantly Delevers Balance Sheet Arrayed Notes Acquisition Corp to Become Majority Equity Holder of Velo3D
AGM Group Holdings Inc. Highlights Strategic Growth and Future Initiatives in AI and Cryptocurrency
BEIJING, Dec. 24, 2024 /PRNewswire/ — AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, released a statement of its CEO Dr. Bo Zhu today, discussing the Company’s growth strategies and future initiatives in the cryptocurrency industry.… Continue reading AGM Group Holdings Inc. Highlights Strategic Growth and Future Initiatives in AI and Cryptocurrency
Gulf Oil and Nayara Energy forge partnership to expand nationwide distribution
Gulf Oil Lubricants India Ltd. has entered into a strategic partnership with Nayara Energy to expand its automotive product offerings across India. Nayara Energy, the largest private fuel retailer in the country, operates an extensive network of over 6,500 fuel stations nationwide. This collaboration aims to make Gulf’s range of automotive products, including lubricants for… Continue reading Gulf Oil and Nayara Energy forge partnership to expand nationwide distribution
Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ — Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing Company (a fully-owned subsidiary of Astra Industrial Group), a leading pharmaceutical company in the Middle East and North Africa (MENA) region, for… Continue reading Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029
BOSTON, Dec. 24, 2024 /PRNewswire/ — According to the latest study from BCC Research, “Global Multiomics Market” is expected to grow from $2.7 billion in 2024 to $5.1 billion by the end of 2029, at a compound annual growth rate of 13.5%. Interesting Facts: Multiomics advances therapeutic target and biomarker discovery by linking genotype to phenotype. The… Continue reading Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029
GW Instek feiert 50 Jahre Innovation und bereitet sich auf eine neue Reise in das Jahr 2025 vor
Mit fünf Jahrzehnten technologischer Expertise im Rücken feiert GW Instek sein 50-jähriges Bestehen, indem es erstklassige Testlösungen für Schlüsselindustrien weltweit bereitstellt und sie so in die Lage versetzt, Qualität und Effizienz zu steigern. NEW TAIPEI CITY, 24. Dezember 2024 /PRNewswire/ — GW Instek steht kurz davor, im Jahr 2025 einen Meilenstein zu erreichen und das… Continue reading GW Instek feiert 50 Jahre Innovation und bereitet sich auf eine neue Reise in das Jahr 2025 vor